GRAL vs DGX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DGX Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Quest Diagnostics Inc. (DGX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while GRAL counters with relative strength in Valuation. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus DGX at 21.9x Forward P/E and 14.9% operating margin (+10.0% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against DGX sits in CONSOLIDATION (16th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | GRAL Revenue | DGX Revenue | GRAL Op. Margin | DGX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $7.53B | N/A | 14.6% | DGX |
| FY2019 | N/A | $7.73B | N/A | 15.9% | DGX |
| FY2020 | N/A | $9.44B | N/A | 20.9% | DGX |
| FY2021 | N/A | $10.8B | N/A | 22.1% | DGX |
| FY2022 | N/A | $9.88B | N/A | 14.4% | DGX |
| FY2023 | $90M | $9.25B | -1627.6% | 13.6% | DGX |
| FY2024 | $130M | $9.87B | -1743.0% | 13.6% | DGX |
| FY2025 | $150M | $11.0B | -382.0% | 14.1% | DGX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GRAL | DGX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.2B | $28.6B | Larger Scale | DGX |
| Trailing P/E Ratio Valuation | 1.1x | 25.9x | Lower Multiple | GRAL |
| Forward P/E Ratio Valuation | 1.1x | 21.9x | Lower Multiple | GRAL |
| Revenue Growth (YoY) Growth | +3.7% | +10.0% | Higher Growth | DGX |
| Operating Margin (TTM) Profitability | -332.0% | 14.9% | Higher Margin | DGX |
| Net Profit Margin Profitability | -243.8% | 9.5% | Higher Margin | DGX |
| Return on Equity (ROE) Capital Efficiency | -17.3% | 15.3% | Higher ROE | DGX |
| 52-Week Range Position Momentum | 51% ($42โ$166) | 99% ($171โ$263) | Stronger Trend | DGX |
| Beta / 30D Volatility Risk Regime | 3.09ฮฒ ยท 99% Vol | -0.06ฮฒ ยท 19% Vol | Lower Realized Risk | DGX |
| Unified Institutional Score Composite Signal | 54.5 / 100 (HOLD) | 41.1 / 100 (SELL) | Higher Composite | GRAL |